HIV Alert: Emerging Updates on Dual Therapy

Listen to downloadable audio from a series of live Webinars by Joseph J. Eron, Jr., MD, and Babafemi Taiwo, MBBS, in which the use of a recently approved dual-therapy regimen and data surrounding investigational 2-drug regimens are discussed and audience questions on these subjects are addressed.
Daniel R. Kuritzkes, MD
Paul E. Sax, MD
Format: Audio (.mp3)
File Size: 8.35 MB
Released: January 18, 2018

Listen to downloadable audio from a series of live Webinars by Joseph J. Eron, Jr., MD, and Babafemi Taiwo, MBBS, in which the use of a recently approved dual-therapy regimen and data surrounding investigational 2-drug regimens are discussed and audience questions on these subjects are addressed. (~45 minutes)

Joseph J. Eron, Jr., MD, has disclosed that he has received consulting fees from EMD Serono, Gilead Sciences, Janssen, Merck, Trio Health, and ViiV and funds for research support (to the University of North Carolina) from Gilead Sciences, Janssen, and ViiV.

Babafemi Taiwo, MBBS, has disclosed that he has received consulting fees from Gilead Sciences, Janssen, and ViiV and funds for research support from ViiV.

Acknowledgements

Educational grant provided by:
ViiV Healthcare

Related Content

Expert commentary from Anton L. Pozniak, MD, FRCP, on how new data from AIDS 2018 will impact his treatment of HIV, as reported to Clinical Care Options (CCO).

Anton L. Pozniak, MD, FRCP Released: August 10, 2018

AIDS 2018: Slides from CCO’s official coverage of International AIDS Conference (IAC), as chosen by expert HIV faculty Eric Daar and Chloe Orkin.

Eric S. Daar, MD Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: August 9, 2018

Clinical Care Options’ summary of Week 100 data presented at AIDS 2018 from SWORD-1, -2 studies of dolutegravir plus rilpivirine as maintenance therapy.

Released: July 31, 2018

Clinical Care Options’ summary of AIDS 2018 report on subgroup analysis of BRIGHTE study on salvage therapy with HIV-1 attachment inhibitor fostemsavir.

Released: July 30, 2018

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?